Chagas' disease is caused by the protozoan Trypanosoma cruzi which infects 10-15 million people in endemic areas throughout Latin America and is naturally transmitted by insect vectors of the family Reduviidae.
studies indicate patients' Ab and cell-mediated responses to EPI show differences between C-and I-patients. PBMC from I-patients responded more often to high molecular weight components (100-150 kD) , while both I-and C-patients responded well to moieties between 28-32 and 48-57 kD. All chagasic patients' sera had Abs and PBMC responses to T. cruzi GP57/51 antigen.
Chronic Chagas' patients have peripheral blood anti-Id T cells that respond to anti-EPI Abs purified from patients' sera. Some patients' PBMC anti-Id responses to anti-EPI Ids from C-patients (Id-C) are inhibited by chloroquine (Group 1) , but some are not inhibited by chloroquine, anti-HLA Class II antigens, or sodium azide (Group 2) . Most patients in Group 1 are asymptomatic, but all Group 2 patients have severe disease. Direct (non-processed; non-MHC-presented) stimulation of anti-Id T cells from C-patients by Ids expressed on anti-EPI Abs from C-patients could be immunopathogenic.
Anti-Id specific rabbit sera detect Id differences in the anti-EPI Abs from pooled or individual C vs. I-cases. Competitive ELISA assays and Western blot analyses of Abs show that Ids on I-patients' anti-EPI Abs are primary structure expressions, while Ids on C-patients' anti-EPI Abs are defined by intact Ab molecules.
The chronic, endemic nature of Chagas' disease allows maternal/neonatal Id interactions that might influence later immune response and immunoregulatory abilities of children born of infected mothers. Such interactions occur because cord blood mononuclear cells from chagasic mothers' children respond to Ids on anti-EPI Abs. A hypothesis based on Id-induced pathology and immunoregulation will be described that could account for certain aspects of the immunology and pathology of Chagas' disease.
History and prevalence
Chagas' disease (South American Trypanosomiasis) is an endemic zoonosis produced by Trypanosoma cruzi which is found presently only in the Americas. The disease is named for the 29 year old Brazilian physician, Carlos Chagas, who in 1909 identified and described the parasite in the hind-gut of insects from the family Reduviidae. Dr. Chagas later observed its pathogenicity in mammals and located and described many of the domestic (dogs, cats, goats, etc.) and wild (armadillo, opossum, etc.) reservoirs. He went on to demonstrate this infection in humans and described its acute and chronic stages. Recent epidemiologic studies in South America suggest there may be 10 to 15 million people serologically positive for T. cruzi (Brener, 1982; Chagas, 1988) . Reports on the incidence of infection crudely estimate it to be over 800,000 new cases each year with an annual mortality of around 60,000 (Dias, 1987) .
Like many parasitic infections, Chagas' disease is most common in, but not confined to, people occupying the lower socioeconomic classes. Contact with the vector and transmission have been correlated most strongly to poor housing construction and inadequate vector control (Marsden, 1984) . These factors play a major role in transmission of Chagas' disease as the vector and trypanosome are much more widely distributed than is human infection (Grogl et al., 1984; Beard et al., 1988; Yaeger, 1988) . Transmission in endemic areas is largely vector-related and thus limited to the Americas, but recent reports have shown that congenital passage (Azogue et al., 1985) , laboratory accidents (Brener, 1987) , organ transplants and blood transfusions (Kirchhoff, 1989 ) play a considerable role in transmission in endemic countries and may become a serious problem for non-endemic countries as well. Two recent reports of transfusion related T. cruzi infection in North American hospitals have stressed the danger which T. cruzi contaminated blood could pose for non-endemic countries (Grant et al., 1989; Nickerson et al., 1989 Brazil to Japan, transfusion related Chagas' disease may become something that the Japanese medical community will need to consider in the future.
Biology of Trypanosoma cruzi
Trypanosoma cruzi has a complex life cycle involving both vertebrate and invertebrate hosts (Pereira, 1990) . Under natural conditions, the trypanosome is transmitted to its definitive mammalian host via the feces or urine of an infected reduviid bug of the genera Triatominae, Rhodnius, or Panstrongylus (Ghauri, 1973) . Those strictly hematophagous reduviids which are the most efficient vectors of human infections defecate shortly after taking a blood meal. The feces and urine contain the infectious trypomastigote stage which develops from the non-infectious, asexually dividing epimastigote form found in the hind-gut of the vector. Trypomastigotes cannot penetrate intact epidermis but enter through breaks in the skin or through intact mucous membranes. Therefore, infection is not due to a direct inoculation by the insect vector, but rather indirectly through the victim wiping and scratching at the bite and subsequently contaminating the wound, their eyes or mouth. Evidence of primary infection is sometimes seen at the site of entry as localized inflammatory reaction resulting in an indurated nodule at the bite (chagoma) or by unilateral periorbital swelling and conjunctivitis (Romana's sign) .
The non-dividing blood stage trypomastigote form has the well described ability to avoid complement lysis Rimoldi et al., 1988 ) and phagocyte killing (Osuna et al., 1986; Reed, 1988; Reed et al., 1989) and is capable of receptor mediated entry of a wide variety of host cell types (Velge et al., 1988; Davis and Kuhn, 1990) . Once inside the cell the trypomastigote produces a recently described perforin-like molecule, analogous to C9 of the complement cascade, and passes from the parasitoferous vacuole into the cytoplasm of the cell (Andrews et aL, 1990 Ottesen, 1984) . These findings suggest that there are many individuals within endemic populations who are somehow able to better modulate the severity of disease in the acute, and possibly chronic, phases of infection with parasites.
When acute chagasic infection is clinically apparent it is usually defined by a marked parasitemia with symptoms ranging from mild fatigue and fever to severe myocarditis and death (5-10% of acute patients) (Nogueira, 1986) . Diagnosis is made by demonstrating parasites in stained blood smears or live parasite isolation (xenodiagnosis or hemoculture) and is occasionally aided by description of a chagoma or Romana's sign. Diagnosis of acute Chagas' disease by serological testing is generally of little use possibly due to the rapid and severe immunosuppression seen in these patients (Brener, 1980; Kuhn, 1981; Beltz et aL , 1989) .
Because the acute phase is not often recognized, data on cellular and humoral events during acute Chagas' disease are generally not available.
A few reports discuss the humoral response progression during acute accidental infection of laboratory workers from sero-negativity through to seroconversion and frank parasitemia (Brener, 1984 (Brener, , 1987 Hofflin et al., 1987) . But little is known about cellular reactivities during this phase of human infection. The acute phase of experimental Chagas' disease has been widely studied (Teixeira et al., 1975; Tarleton and Scott, 1987) . Acute murine infection with T. cruzi demonstrates a tremendous polyclonal stimulation involving both B and T cells. Nearly half of all spleen cells appear to be blast cells undergoing mitosis. This response is truly polyclonal: all Vhgene families studied (covering more than 95% of the repertoire of the entire locus) are stimulated (Minoprio et al., 1989) . The majority of these activated splenic and lymph node plaque forming cells are not specific for the parasite (Minoprio et al., 1988) . There are no reports in the literature concerning the existence or the extent of this polyclonal activation in humans but its presence has been proposed to play a role in the marked immunosuppression and possible autoimmunity seen in human trypanosomiasis (Petry and Eisen, 1989 (Nogueira, 1986) . Intracellular parasites are believed to maintain a lifelong tissue infection but trypomastigotes are typically scarce or absent in the blood as parasitemia is tightly controlled by the host's immune response. This becomes very apparent in those chronic patients who, for reasons unrelated to their Chagas' disease, receive immunosuppressive therapy and subsequently develop a new "acute" infection complete with patent parasitemia (Brener, 1980; Kierszenbaum et al., 1983; Hudson and Britten, 1985) . In the chronic phase, demonstration of parasitemia is generally very difficult because of the low numbers seen in the peripheral circulation. Simple blood smears are completely useless for diagnostic purposes. This requires very sensitive techniques which rely on a long multiplicative phase either in uninfected reduviid bugs allowed to feed on patients' blood (xenodiagnosis) or in vitro culture (hemoculture) of parasites from patient blood directly. For this reason serology is usually the method of choice for positive diagnosis of chronic Chagas' disease (Brener, 1982) . New approaches using molecular biological techniques such as the polymerase chain reaction (PCR) for highly sensitive and specific, detection of organisms are now being explored (Moser et al., 1989; Sturm et al., 1989) .
Most chronic patients are asymptomatic and typically present with positive serology and sub-patent parasitemia. Between 60% and 80% of people infected with T. cruzi fall into this category and are termed "indeterminate" (Brener and Camargo, 1982) . By definition, these people do not suffer from disease related morbidity and mortality, but this does not mean that they are free from pathology caused by their infections. A series of autopsies performed on Chagas' disease represent a progression rather than distinct and unrelated disease states.
Why certain infected individuals progress more rapidly to morbidity while others regulate the infection their entire lives without clinically apparent disease is not known.
The minority of chronic patients (20-30% ) demonstrate a more severe chronic course (Brener and Camargo, 1982) . Patients with the "cardiac" clinical form demonstrate severe lesions to the conducting and muscular structures of the heart which commonly lead to a dilative cardiomyopathy and congestive heart failure. Lesions of the conducting system of the heart may lead to right bundle branch block and life threatening arrhythmias. This is evident in electrocardiographic changes, and rich inflammatory infiltrates can be demonstrated in post-mortem sections of the heart-often in the absence of demonstrable parasites or parasite antigens (Andrade et al., 1978 This was one of the first findings which suggested a mechanism for the lesions to heart and digestive tract tissues and implicated an autoimmune etiology. These EVI antibodies reacted with human, mouse, bovine and guinea pig heart tissue from non-infected subjects. In these studies, similar cross-reactive antibodies were found in over 90% of patients with chronic chagasic cardiopathology.
Later Cell transfer studies by Laguens and colleagues gave the first evidence suggesting a T cell-mediated autoimmune etiology in experimental Chagas' disease (Laguens et al., 1981) .
These studies used "parasite-free" non-adherent spleen cells isolated from infected mice to create lesions in non-infected syngeneic recipient mice only 4 days after cell transfer. In similar studies, some recipient animals later died of T. cruzi infections so that parasite generated pathology could not be ruled out. Recently, Hontebeyrie-Joskowicz and coworkers have used CD4+T cell clones to create truly parasite free pathology in an MHCrestricted manner in healthy mice. These CD4+clones were shown to have specificity for There have been a number of studies examining humoral responses of patients infected with T. cruzi (Kuhn, 1981; Snary, 1985; Nogueira, 1986) . Recent research has compared patients' antibody responses by Western immunoblotting against separated EPI in parallel with their cell-mediated responses by T cell-Western blotting (Gazzinelli et al., 1988a .
These experiments have shown some differences between C and I patients. PBMC from I patients responded more often to high molecular weight EPI components (100-150 kD) while both C and I patients cells responded to molecules in the 28-32 kD and 48-57 kD ranges. cruzi responded to soluble antigen from epimastigotes but not from unrelated antigens (Eloi- Santos et al., 1988) . Their studies also showed that anti-EPI antibodies, but not antischistosome egg antigen antibodies (anti-SEA) or normal human Ig, stimulated these CBMC.
Furthermore, anti-EPI Ids did not stimulate CBMC from neonates of uninfected or Schistosoma mansoni-infected mothers. These data strongly support the hypothesis that in utero sensitization of anti-Id T-cells occurs. We further hypothesize that such powerful influences on the developing repertoire of the neonate play an important role in determining the responses and regulatory mechanisms expressed by most children in endemic areas when they are subsequently exposed to the same chronic infection.
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